Cancer Grand Challenges
@CancerGrand
Daring to solve some of the most complex challenges in cancer research | Founded by: @CR_UK & @theNCI
📜New in @ScienceMagazine: not one but two papers from team MATCHMAKERS! The labs of David Baker @UWproteindesign and Chris Garcia @StanfordEMED published work that could revolutionise immunotherapy. The Baker lab unveil a generative AI pipeline to design precise binders for…
Cracking Day 1 keynote talk by Prof Balmain at #PrevConf25: Cancer prevention isn’t just about avoiding mutations. Non-mutagenic environmental factors can promote tumours — highlighting a broader, critical window for intervention. Research funded by @CancerGrand
The PRECISION team have developed a deep‑learning model to accurately predict invasive recurrence of DCIS in patients that have been treated with breast-conserving surgery. Published in @eBioMedicine the model has the potential to reduce overtreatment 🔗doi.org/10.1016/j.ebio…
We are hiring! 🚨 Great opportunity to be at the forefront of cancer research on a global scale as a Research Portfolio Manager (based in our London office 2 days a week). Closing date: 1 July 2025 Get in touch with the team to learn more📩 More info 👇 linkedin.com/jobs/view/4252…
Challenge: Develop methods to identify the functional role of the tumour microenvironment over time Awards of up to £20M available for global interdisciplinary teams EOI deadline: 18 June Apply: bit.ly/42P3wEe
A massive thank you to everyone at #CGCecDNA, especially our co-organisers @mischellab, Mariam Jamal-Hanjani and @HowardYChang, and all of our fantastic speakers! Together we’ll tackle the challenge of extrachromosomal DNA.
That’s a wrap on #CGCecDNA! Congratulations to our poster prize winners @ShirMarom, Yifat Bar Or Snarski and Alexandra Chelu!
Zhijian (James) Chen, recently elected as a foreign member of the @royalsociety, brought the scientific programme of #CGCecDNA to a close by discussing ecDNA sensing pathways and harnessing them to target ecDNA positive cancers.
@samuels_yardena took us through revisiting the neoantigen approach to cancer immunotherapy with an ecDNA lens #CGCecDNA
We kicked off the final day of #CGCecDNA with Ben Cravatt (@scrippsresearch) and innovative chemical approaches to target ecDNA in cancer.
One of our seven new challenges: AI-human collaborations in cancer Awards of up to £20M available for global interdisciplinary teams EOI deadline: 18 June 2025 Apply now 👉bit.ly/42P3wEe
